CDC: Rates of new diagnosed cases of type 1 and type 2 diabetes on the rise among children, teens

Rates of new diagnosed cases of type 1 and type 2 diabetes are increasing among youth in the United States, according to a report published today in the New England Journal of Medicine, entitled “Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.”

In the United States, 29.1 million people are living with diagnosed or undiagnosed diabetes, and about 208,000 people younger than 20 years are living with diagnosed diabetes. This study is the first ever to estimate trends in new diagnosed cases of type 1 and type 2 diabetes in youth (those under the age of 20), from the five major racial/ethnic groups in the U.S.: non-Hispanic whites, non-Hispanic blacks, Hispanics, Asian Americans/Pacific Islanders, and Native Americans. Learn more

FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty. Learn more.

 

Daily Progress: Health summit turns its focus toward opioid epidemic

The opioid epidemic weighed heavily on the 400-plus attendees at a statewide conference on population health, which kicked off Wednesday afternoon at the Omni Charlottesville Hotel.

The annual conference, now in its third year, brings together health care providers, social workers and nonprofit organizations to share information on controlling health care problems on a large scale.

This year, organizers said they’re giving extra attention to the opioid epidemic, which claimed almost 1,100 lives in Virginia in 2016, according to projected numbers from the Office of the Chief Medical Examiner of Virginia. Opioid overdoses now outpace traffic accidents as a cause of death in Virginia.

Learn more

Physio-Control Inc. Recalls LIFEPAK 1000 Defibrillator Due to an Electrical Issue Which May Cause the Device to Shut Down Unexpectedly

The LIFEPAK 1000 Defibrillator has been recalled due to an electrical issue, which may cause the device to shut down unexpectedly. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Learn more about this recall.

Recalled Product:

  • The LIFEPAK 1000 defibrillator
  • Affected Product Part Numbers: 320371500XX
  • Serial Numbers: There are 133,330 affected serial numbers. Search Affected Devices
  • Distribution Dates: June 30, 2006 to December 23, 2016
  • Manufacturing Dates: June 30, 2006 to December 20, 2016
  • Devices Recalled in the U.S.: 50,046 nationwide

CDC identifies potential risk of Zika virus transmission since June 15, 2016, in Miami-Dade, Broward, and Palm Beach counties

CDC has identified a potential risk of Zika virus transmission starting on June, 15, 2016, to present in Miami-Dade County, Florida, that also could affect risk for residents of Broward and Palm Beach counties. CDC recently collaborated with the Florida Department of Health to conduct additional analysis of locally acquired Zika cases, including analysis of resident travel patterns between Miami-Dade, Broward, and Palm Beach counties. This analysis has led to CDC identifying that since June 15, 2016, there has been a potential increased Zika risk for residents in Broward and Palm Beach counties because of local travel to areas of active transmission in Florida and challenges associated with defining sources of exposure. This increased risk is particularly relevant for semen because of evidence regarding the persistence of Zika virus in this reproductive tissue.  Learn more

CDC: Multistate Outbreak of Shiga toxin-producing E. coli Infections Linked to I.M. Healthy Brand SoyNut Butter

CDC, multiple states, and the U.S. Food and Drug Administration (FDA) are investigating a multistate outbreak of Shiga toxin-producing Escherichia coli O157:H7 (STEC O157:H7) infections. Twelve people infected with the outbreak strain of STEC O157:H7 have been reported from five states. Epidemiologic evidence available at this time indicates that I.M. Healthy brand SoyNut Butter is a likely source of this outbreak. I.M. Healthy brand SoyNut Butter may be contaminated with E. coli O157:H7 and could make people sick. Learn more

Advice to consumers

Recall notice

Johns Hopkins: Painkillers often stored within reach of small children

According to a new study from the Johns Hopkins Bloomberg School of Public Health, nearly 70 percent of prescription opioid pain medications (such as codeine and hydrocodone) kept in homes with children are not stored safely.

In a 2015 national online survey, researchers identified 681 adults who had used opioid pain relievers in the past year and had children ages 17 and younger living with them. Only 31 percent reported safely storing prescriptions away from their children. Among those homes with children 7 to 17 years old, just 12 percent reported safe storage.

Learn more

NIH: Youth with type 2 diabetes develop complications more often than type 1 peers

Teens and young adults with type 2 diabetes develop kidney, nerve, and eye diseases – as well as some risk factors for heart disease – more often than their peers with type 1 diabetes in the years shortly after diagnosis. The results are the latest findings of the SEARCH for Diabetes in Youth study, published Feb. 28 in the Journal of the American Medical Association. Learn more